DUBLIN–(BUSINESS WIRE)–Horizon announces that the American Journal of Ophthalmology has published a review highlighting the lack of treatments for active thyroid eye disease
Author: Business Wire
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
GENEVA–(BUSINESS WIRE)–Alcon Launches New PRECISION1 Contact Lenses that Deliver Superior Performance Over #1 Selling Daily Disposable
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
GENEVA–(BUSINESS WIRE)–Alcon Launches New PRECISION1 Contact Lenses that Deliver Superior Performance Over #1 Selling Daily Disposable
OSCAR WYLEE Introduces a Joint Venture Partnership for Optometrists and Optical Dispensers
SYDNEY–(BUSINESS WIRE)–OSCAR WYLEE Introduces a Joint Venture Partnership for Optometrists and Optical Dispensers
CLARIUM Lens Launches a Wider Range of Premium Quality Lens Products
SINGAPORE–(BUSINESS WIRE)–Clarium Lens, a technological innovator in the field of optics, extends its range of Clarium Lux lens products. The Clarium Lux range is designed to address the growing number of vision problems that limit visual perception….
China Eye Glasses Industry Report 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Report on the Chinese Glasses Industry 2018-2023” report has been added to ResearchAndMarkets.com’s offering. The Chinese glasses market saw a total of CNY 78.17 million in retail figures in 2017. Contact lens sales generated a total of CNY 7.108 billion, while glasses for the elderly generated a total of CNY 1.108 billion in sales. Sunglasses sold for a total of CNY 28.903 million in sales figures. Glasses are simple instruments designed to correct or protect visi
Compulink Announces Agreement to Acquire MyEyeStore®
NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink announces agreement to acquire MyEyeStore.
Lineage Cell Therapeutics Launches New Corporate Brand
CARLSBAD, Calif.–(BUSINESS WIRE)–<a href=”https://twitter.com/search?q=%24LCTX&src=ctag” target=”_blank”>$LCTX</a> <a href=”https://twitter.com/hashtag/AMD?src=hash” target=”_blank”>#AMD</a>–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced the effective change of its corporate name and formal launch of its new corporate brand. In connection with the launch, the Company’s NYSE American ticker symbol has changed to “LCTX” and will be effective at the open of the market today. The new website for Lineage Cell Therapeutics wil
AtriCure Enters Into Definitive Agreement to Acquire SentreHEART
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has entered into a definitive agreement to acquire SentreH…
Quidel Reports Second Quarter 2019 Financial Results
SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 20…
BioTime Reports Second Quarter 2019 Financial Results and Provides Business Update
ALAMEDA, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24BTX&src=ctag" target="_blank">$BTX</a> <a href="https://twitter.com/hashtag/AMD?src=hash" target="_blank">#AMD</…
Omeros Corporation Reports Second Quarter 2019 Financial Results
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications ta…
Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company’s new drug application (NDA) for KPI-1…
Global Contact Lens Market 2015-2019 & 2025: Forecast by Segments, Materials, Design, and Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Contact Lens Market, Global Forecast by Segments (Corrective Lens, Cosmetic & Lifestyle oriented Lens, Others), Materials, Design, Companies” report has been added to ResearchAndMarkets.com’s offering. Global contact lens market is expected to surpass US$ 12 Billion by the year-end of 2025. The major factors that fuel the market growth are; rising per capita income, increasing disposable income, increasing awareness about eye care treatment, growing ageing popu
Domain Associates-backed OcuNexus Therapeutics Making Significant Progress with Inflammasome Inhibition Program in Ophthalmic Disease with Key Addition to Board of Directors
SAN DIEGO–(BUSINESS WIRE)–OcuNexus Therapeutics, a clinical stage biotechnology company developing a first-in-class orally administered treatment for the dry form of age-related macular degeneration and diabetic retinopathy, today announced that it h…
Aldeyra Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update
LEXINGTON, Mass.–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24ALDX&src=ctag" target="_blank">$ALDX</a>–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing…
Aerpio Reports Second Quarter 2019 Financial Results and Provides Business Update
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial results for the secon…
Glaukos Corporation Announces Second Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Glaukos Corporation Announces Second Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Glaukos and Avedro Announce Definitive Acquisition Agreement
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, and Avedro, Inc. (Nas…